Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Operating Income (2020 - 2025)

PROCEPT BioRobotics has reported Operating Income over the past 6 years, most recently at -$31.0 million for Q4 2025.

  • Quarterly results put Operating Income at -$31.0 million for Q4 2025, down 57.49% from a year ago — trailing twelve months through Dec 2025 was -$103.9 million (down 7.5% YoY), and the annual figure for FY2025 was -$103.9 million, down 7.5%.
  • Operating Income for Q4 2025 was -$31.0 million at PROCEPT BioRobotics, down from -$23.2 million in the prior quarter.
  • Over the last five years, Operating Income for PRCT hit a ceiling of -$11.3 million in Q1 2021 and a floor of -$31.0 million in Q4 2025.
  • Median Operating Income over the past 5 years was -$22.8 million (2024), compared with a mean of -$22.2 million.
  • Biggest five-year swings in Operating Income: tumbled 80.7% in 2023 and later surged 33.32% in 2024.
  • PROCEPT BioRobotics' Operating Income stood at -$16.8 million in 2021, then crashed by 48.77% to -$25.0 million in 2022, then dropped by 18.04% to -$29.6 million in 2023, then surged by 33.32% to -$19.7 million in 2024, then tumbled by 57.49% to -$31.0 million in 2025.
  • The last three reported values for Operating Income were -$31.0 million (Q4 2025), -$23.2 million (Q3 2025), and -$22.2 million (Q2 2025) per Business Quant data.